HEB Stock | News | Quote | Stock Forum | Tuesday, December 10,

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
$HEB Hemispherx BioPharma, Inc. HEB Company Overview 

Hemispherx BioPharma, Inc. HEB Current Price and Quotes
Last Price 0.3151
Previous Close 0.197 Open 0.2448
Daily Range 0.4088 - 0.24 52wk Range 0.789 - 0.18
Volume 23,486,940 Dividend N/A
Average Vol (3m) 384,886 Yield N/A

HEB Stock Message Board http://investorshangout.com/search?q=HEB&...mp;yt1=Go!

Last Updated: Tuesday, December 10, 2013 01:29:15 AM

Hemispherx BioPharma, Inc. HEB
Company Information

1617 JFK Boulevard
Suite 660
Philadelphia, PA 19103

Website: http://www.hemispherx.net
Phone: (215) 988-0080

Hemispherx BioPharma, Inc. HEB
Not Available

Hemispherx BioPharma, Inc. HEB
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Latest Report Sep 30, 2013 10-Q
CIK 0000946644
Fiscal Year End 12/31
OTC Marketplace Not Available
Profile Data

SIC - Industry Classification Not Available
Incorporated In: DE, USA
Year of Inc. Not Available
Employees Not Available
Service Providers

Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available

Hemispherx BioPharma, Inc. HEB
HEB Security Details

Share Structure

Market Value1 $39,406,339 a/o Dec 09, 2013
Shares Outstanding 167,686,551 a/o Nov 01, 2013
Float Not Available
Authorized Shares Not Available
Par Value  0.001
Shareholders

Shareholders of Record 256 a/o Mar 17, 2008
Short Selling Data

Short Interest  (%)
Significant Failures to Deliver  No
Transfer Agent(s)

Continental Stock Transfer & Trust Company

Hemispherx BioPharma, Inc. HEB Financials
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Dec 31, 2009
Total Revenue 213 161 135 111
Cost of Revenue 1,989 1,043 1,341 584
Gross Profit (1,776) (882) (1,206) (473)
Operating Expenses

Research and Development 9,508 6,722 7,613 6,995
Sales, General and Admin. 9,056 6,691 7,568 5,796
Non-Recurring Items - - - -
Other - - - -
Operating Income (20,340) (14,295) (16,387) (13,264)
Income From Continuing Operations

Add'l Income/Expense Items 3,010 5,321 3,262 6,084
Earnings Before Interest and Tax (17,330) (8,974) (13,125) (7,180)
Interest Expense 24 41 11 -
Earnings Before Tax (17,354) (9,015) (13,136) (7,180)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (17,354) (9,015) (13,136) (7,180)
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (17,354) (9,015) (13,136) (7,180)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (17,354) (9,015) (13,136) (7,180)

Hemispherx BioPharma, Inc. HEB Recent News

Dec 9, 2013 FDA Authorizes Expansion of Ampligen/FluMist Intranasal Clinical Trial Designed to Elicit Potential Protection Against Many Pre-Pandemic Influenza Viruses
Dec 4, 2013 Hemispherx Biopharma Appoints New Chief Financial and Chief Accounting Officers
Dec 2, 2013 Hemispherx Biopharma and the University of Pittsburgh Collaborate on a Novel Chemokine-Modulatory Program for Cancer Immunotherapies With Ampligen(R) as a Key Component
Nov 19, 2013 Hemispherx Biopharma Sponsors Chronic Fatigue Syndrome Conference at Mount Sinai Medical Center in New York
Nov 8, 2013 Hemispherx Biopharma Announces Financial Results for the Three Months Ended September 30, 2013
Oct 18, 2013 Hemispherx Biopharma Reports on Annual Stockholder Meeting
Oct 3, 2013 Hemispherx Biopharma's 2013 Stockholder Annual Meeting Proposal 4 Removed From Stockholder Consideration
Sep 20, 2013 Faruqi & Faruqi, LLP Launches An Investigation Against Hemispherx Biopharma, Inc. (HEB) For Potential Breaches Of Fiduciary Duties By Its Board Of Directors
Sep 18, 2013 Hemispherx Biopharma's 2013 Stockholder Annual Meeting Set
Sep 12, 2013 Natural Human Interferon (Alpha-n3) is Active Against Both Wild-Type and Oseltamivir Resistant Avian-Origin Influenza A (H7N9) Virus

1
2
next >

HEB Hemispherx BioPharma, Inc. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=HEB&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/HEB/quote
Stock Chart http://www.otcmarkets.com/stock/HEB/chart
Company Info http://www.otcmarkets.com/stock/HEB/company-info
Recent News http://www.otcmarkets.com/stock/HEB/news
Financials http://www.otcmarkets.com/stock/HEB/financials
Filings and Disclosure http://www.otcmarkets.com/stock/HEB/filings
Short Sales http://www.otcmarkets.com/stock/HEB/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/HEB/insider-transactions
Research Reports http://www.otcmarkets.com/stock/HEB/research
Summary http://finance.yahoo.com/q?s=HEB
Historical Prices http://finance.yahoo.com/q/hp?s=HEB+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=HEB
Basic Chart http://finance.yahoo.com/q/bc?s=HEB+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=HEB+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=HEB+Headlines
Press Releases http://finance.yahoo.com/q/p?s=HEB+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=HEB+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=HEB+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=HEB+Industry
Major Holders http://finance.yahoo.com/q/mh?s=HEB+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=HEB+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=HEB+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=HEB
Balance Sheet http://finance.yahoo.com/q/bs?s=HEB
Cash Flow http://finance.yahoo.com/q/cf?s=HEB+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/HEB
Market Watch http://www.marketwatch.com/investing/stock/HEB
Bloomberg http://www.bloomberg.com/quote/HEB:US
Morningstar http://quotes.morningstar.com/stock/s?t=HEB
Bussinessweek http://investing.businessweek.com/research/st...ticker=HEB
Barchart http://www.barchart.com/quotes/stocks/HEB
OTC Short Report http://otcshortreport.com/index.php?index=HEB
Investopedia http://www.investopedia.com/markets/stocks/HEB/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

SanMar’s Lott Tops Promo Products Power 50 Again in 2026

Updated Category News Views 207

Branded hoodies and logo tumblers rarely make Wall Street’s pulse race, but the numbers behind them deserve a hard look. Jeremy Lott, president and CEO of SanMar, was named the most influential leader in the U.S. promotional-products business for the second consecutive year, taking No. 1 in the 2026 Counselor Power 50 ranking. Awards can be fluff. A repeat win beside...

Continue Reading
Concierto's Azure Push Puts Sovereignty on Display

Updated Category News Views 83

Sovereignty has become the corporate cloud world's favorite hard-edged word. Concierto is taking that word straight onto the Microsoft Ignite 2026 floor, and frankly, it is a sensible place to make the case. The company, part of Trianz, will appear as a Gamechanger Sponsor from November 17 through 20 at San Francisco's Moscone Center, showing its platform at Booth #5435....

Continue Reading
Navan’s Travel Survey Sells Friction as a Business Case

Updated Category News Views 167

A forgotten charger can turn a routine trip into a small mutiny. That is the useful little truth sitting underneath Navan’s new survey of 2,000 Americans who travel for leisure or business. The company is poking at the annoyances people carry from the bedroom packing pile to the jet bridge: forgotten items, rushed airport arrivals, pre-flight drinks, chatty strangers,...

Continue Reading
TRUSTA Targets AI Inference's GPU Memory Squeeze Hard

Updated Category News Views 87

GPU scarcity has turned ordinary server parts into strategic assets, and TRUSTA is leaning right into that uncomfortable fact at SuperComputing 2026. The enterprise-storage brand under ADATA is pitching an upgraded AI Scaler Toolkit built around a fairly sensible premise: companies running large-language-model inference should not have to buy another armful of expensive...

Continue Reading
AMP Tests Debt Market With €1.25 Billion Green Notes

Updated Category News Views 62

Refinancing season has arrived early at Ardagh Metal Packaging, and it is carrying a hefty €1.25 billion price tag. AMP has launched senior secured floating-rate green notes, with proceeds intended to retire two batches of secured debt due in 2028 and leave additional cash on the balance sheet for general corporate purposes, including capital expenditure. This is not...

Continue Reading
Linux Foundation Unveils the Global Fraud Alliance

Updated Category News Views 173

Who would have thought the tech wizards at the Linux Foundation would step up to tackle fraud on a global scale? That's what we've got with their latest play: the Open Financial Trust Alliance (OFTA). Launched at the Singapore FinTech Festival, they've got their sights on connecting the world's disconnected fraud fight. Think of it as a translator for the tangled mess of...

Continue Reading
Sola's 11-Step Push Makes Salon Ownership Less Blind

Updated Category News Views 296

A pristine studio does not pay rent by itself. That is the uncomfortable little truth sitting underneath Sola Salons’ new 11-step roadmap for beauty professionals considering salon-suite ownership. The company is telling stylists, estheticians, nail technicians, massage therapists, and other independent operators to treat the move from commission work to ownership like...

Continue Reading
LASIK Cost Math Deserves a Careful Second Look Today

Updated Category News Views 188

Thirty years of lens purchases can become a nasty tab Contact-lens spending has a funny way of staying invisible until somebody stacks the receipts into one ugly pile. A new cost-of-vision analysis from the surgeon advisory board of BestLASIKSurgeons.com says the average American contact-lens wearer may spend between $22,500 and $30,000 on corrective eyewear across 30...

Continue Reading
Docusign Pushes Contract Data Into ChatGPT Sales Tools

Updated Category News Views 187

Contracts are where sales momentum goes to get lost, buried under old PDFs, approval chains, and somebody’s half-finished CRM note. Docusign’s November 17, 2026 launch is a sensible attempt to drag that information into the place sellers may increasingly spend their working day: ChatGPT for Sales. The company’s new plugin lets a sales rep pull agreement intelligence...

Continue Reading
Paratus on the Move: Seagems JV Under the Microscope

Updated Category News Views 194

What's Cooking with Paratus Energy? Paratus Energy Services Ltd. (ticker: PLSV) just threw us a curveball, announcing a strategic review of its participation in the Seagems joint venture. Now, before you get too jazzed about ticker talk—hold your horses. No one's making any promises about transactions just yet. The decision's still hanging in the balance, even as they...

Continue Reading

Top 5 Most Recently Viewed Articles

Lexicon Pharmaceuticals Unveils Q3 Financials and Future Plans

Updated Category News Views 138

Third Quarter Financial Highlights of Lexicon Pharmaceuticals Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) has disclosed its financial performance for the third quarter of 2025, highlighting significant revenue increases attributed primarily to strategic licensing agreements and product sales. Strategic Partnerships and Revenue Growth In an impressive leap, Lexicon's...

Continue Reading
Growing Innovations in Robotic Dentistry to 2034 and Beyond

Updated Category News Views 178

The Rise of Robotic Dentistry and Its Market Growth The shift towards technological integration in the healthcare sector has begun a revolutionary transformation in dental care. The robotic dentistry market is anticipated to grow significantly, projected to increase from USD 617.39 million in 2024 to an approximate USD 2.24 billion by 2034. This acceleration is based on a...

Continue Reading
Chipotle Lawsuit Update: Key Actions for Shareholders

Updated Category News Views 126

Important Information for Chipotle Shareholders Shareholders of Chipotle Mexican Grill, Inc. (NYSE: CMG) are being advised about an ongoing class action lawsuit that could impact their investments. It is vital for all affected shareholders to take note of critical deadlines and actions they need to undertake to ensure their rights and potential recoveries are protected....

Continue Reading
Quisitive Technology Solutions Reports Q2 2024 Financial Results

Updated Category News Views 144

Quisitive Reports Second Quarter 2024 Financial Results Quisitive Technology Solutions Inc. (“Quisitive” or the “Company”) (TSXV: QUIS, OTCQX: QUISF), a leading provider of Microsoft Cloud and AI solutions, has announced its financial results for the second quarter ending June 30, 2024. Management Commentary Quisitive's CEO, Mike Reinhart, commented, “The first...

Continue Reading
Natural Grocers Reports Strong Fiscal 2024 Performance

Updated Category News Views 231

Natural Grocers by Vitamin Cottage Sees Remarkable Growth in Fiscal 2024 Natural Grocers by Vitamin Cottage, Inc. (NYSE: NGVC) has unveiled its financial results for the fourth quarter and full year of fiscal 2024. The report highlights significant sales and earnings achievements, showcasing the company’s robust performance in a competitive grocery market. Exceptional...

Continue Reading